Product information
From Health Canada
Current status:
Dormant
Current status date:
2020-01-14
Original market date: See footnote 1
1994-12-31
Product name:
DIOPTICON A LIQ
DIN:
02026465 Electronic product monograph is not available
Company:
PHARMA STULLN INC.
6500 Trans Canada Highway, Suite 400
Pointe-Claire
Quebec
Canada
H9R 0A5
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Ophthalmic
Number of active ingredient(s):
2
Schedule(s):
OTC
American Hospital Formulary Service (AHFS): See footnote 3
04:04.20 , 52:32.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
S01GA51 NAPHAZOLINE, COMBINATIONS
Active ingredient group (AIG) number:See footnote5
0213722002
Active ingredient(s) | Strength |
---|---|
NAPHAZOLINE HYDROCHLORIDE | 0.025 % |
PHENIRAMINE MALEATE | 0.3 % |